Mark A Glickman Insider Trading $AUXL AUXILIUM PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark A Glickman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark A Glickman. Mark A Glickman is EVP - Sales and Marketing in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Mark A Glickman in AUXILIUM PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark A Glickman: EVP - Sales and Marketing
Holdings: 0 shares
Latest Transaction: Jan 30 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Mark A Glickman in AUXILIUM PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30 2015 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Option Exercise | J | 28.30 | 31,200 | 882,960 | 0 | |
| Jan 30 2015 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Option Exercise | J | 18.30 | 24,750 | 452,925 | 0 | |
| Jan 30 2015 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Option Exercise | J | 26.87 | 5,000 | 134,350 | 0 | |
| Jan 30 2015 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Option Exercise | J | 20.07 | 27,500 | 551,925 | 0 | |
| Jan 30 2015 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Sell | J | 36.53 | 27,911 | 1,019,589 | 0 | 27.9 K to 0 (-100.00 %) |
| Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Option Exercise | M | 18.30 | 8,250 | 150,975 | 24,750 | |
| Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Option Exercise | M | 26.87 | 5,000 | 134,350 | 5,000 | |
| Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Option Exercise | M | 20.07 | 27,500 | 551,925 | 27,500 | |
| Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Sell | S | 33.16 | 40,750 | 1,351,372 | 27,911 | 68.7 K to 27.9 K (-59.35 %) |
| Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Sell | S | 33.18 | 7,202 | 238,963 | 68,661 | 75.9 K to 68.7 K (-9.49 %) |
| Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Buy | M | 18.30 | 8,250 | 150,975 | 75,863 | 67.6 K to 75.9 K (+12.20 %) |
| Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Buy | M | 26.87 | 5,000 | 134,350 | 67,613 | 62.6 K to 67.6 K (+7.99 %) |
| Nov 24 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Buy | M | 20.07 | 27,500 | 551,925 | 62,613 | 35.1 K to 62.6 K (+78.32 %) |
| Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Option Exercise | A | 0.00 | 24,000 | 0 | 24,000 | |
| Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Option Exercise | A | 28.30 | 31,200 | 882,960 | 31,200 | |
| Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Grant | A | 0.00 | 12,500 | 0 | 35,113 | 22.6 K to 35.1 K (+55.28 %) |
| Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Payment of Exercise | F | 28.30 | 704 | 19,923 | 22,613 | 23.3 K to 22.6 K (-3.02 %) |
| Feb 20 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Grant | A | 0.00 | 6,375 | 0 | 23,317 | 16.9 K to 23.3 K (+37.63 %) |
| Feb 11 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Payment of Exercise | F | 23.68 | 1,986 | 47,028 | 16,942 | 18.9 K to 16.9 K (-10.49 %) |
| Feb 04 2014 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Payment of Exercise | F | 24.70 | 388 | 9,584 | 18,928 | 19.3 K to 18.9 K (-2.01 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Option Exercise | A | 18.30 | 33,000 | 603,900 | 33,000 | |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Payment of Exercise | F | 18.30 | 426 | 7,796 | 19,316 | 19.7 K to 19.3 K (-2.16 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Grant | A | 0.00 | 13,200 | 0 | 19,742 | 6.5 K to 19.7 K (+201.77 %) |
| Feb 11 2013 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Grant | A | 0.00 | 3,940 | 0 | 6,542 | 2.6 K to 6.5 K (+151.42 %) |
| Feb 05 2013 | AUXL | AUXILIUM PHARMACEU ... | Glickman Mark A | EVP - Sales and Mar ... | Payment of Exercise | F | 18.85 | 398 | 7,502 | 2,602 | 3 K to 2.6 K (-13.27 %) |
Page: 1